| scholarly article | Q13442814 |
| P2093 | author name string | Bein G | |
| Hackstein H | |||
| Kirchner H | |||
| Kutza AS | |||
| Muhl E | |||
| P433 | issue | 5 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | sepsis | Q183134 |
| cytomegaloviral disease | Q2076966 | ||
| Cytomegalovirus | Q6946 | ||
| P304 | page(s) | 1076-1082 | |
| P577 | publication date | 1998-05-01 | |
| P1433 | published in | Clinical Infectious Diseases | Q5133764 |
| P1476 | title | High incidence of active cytomegalovirus infection among septic patients | |
| P478 | volume | 26 |
| Q35662356 | A Prospective Monitoring Study of Cytomegalovirus Infection in Non-Immunosuppressed Critical Heart Surgery Patients |
| Q39456656 | A multisite trial comparing two cytomegalovirus (CMV) pp65 antigenemia test kits, biotest CMV brite and Bartels/Argene CMV antigenemia |
| Q35792205 | Active cytomegalovirus infection in patients with septic shock |
| Q33695591 | Antiviral prevention of sepsis induced cytomegalovirus reactivation in immunocompetent mice |
| Q53840220 | Association Between Cytomegalovirus Reactivation and Clinical Outcomes in Immunocompetent Critically Ill Patients: A Systematic Review and Meta-Analysis. |
| Q39860663 | Breaking human cytomegalovirus major immediate-early gene silence by vasoactive intestinal peptide stimulation of the protein kinase A-CREB-TORC2 signaling cascade in human pluripotent embryonal NTera2 cells |
| Q37025600 | Broncholaveolar lavage to detect cytomegalovirus infection, latency, and reactivation in immune competent hosts |
| Q38297466 | CCAAT/enhancer-binding proteins alpha and beta negatively influence the capacity of tumor necrosis factor alpha to up-regulate the human cytomegalovirus IE1/2 enhancer/promoter by nuclear factor kappaB during monocyte differentiation |
| Q98177684 | CD4 T Cell Responses and the Sepsis-Induced Immunoparalysis State |
| Q37798773 | CMV in critically ill patients: pathogen or bystander? |
| Q38257496 | CMV-encoded Fcγ receptors: modulators at the interface of innate and adaptive immunity |
| Q91975369 | Cytomegalovirus Latency and Reactivation: An Intricate Interplay With the Host Immune Response |
| Q34510887 | Cytomegalovirus and herpes simplex virus effect on the prognosis of mechanically ventilated patients suspected to have ventilator-associated pneumonia |
| Q34583491 | Cytomegalovirus in solid organ transplantation |
| Q42630114 | Cytomegalovirus in the intensive care unit: pathogen or passenger? |
| Q55517117 | Cytomegalovirus infection and outcome in immunocompetent patients in the intensive care unit: a systematic review and meta-analysis. |
| Q37482179 | Cytomegalovirus infection in critically ill patients: a systematic review |
| Q28079509 | Cytomegalovirus infection in immunocompetent critically ill adults: literature review |
| Q37695593 | Cytomegalovirus pneumonia: community-acquired pneumonia in immunocompetent hosts |
| Q39199695 | Cytomegalovirus reactivation and associated outcome of critically ill patients with severe sepsis |
| Q38957959 | Cytomegalovirus reactivation in ICU patients |
| Q35086196 | Cytomegalovirus reactivation in critically ill immunocompetent hosts: a decade of progress and remaining challenges. |
| Q37414600 | Cytomegalovirus reactivation in critically ill immunocompetent patients |
| Q21195897 | Cytomegalovirus-induced immunopathology and its clinical consequences |
| Q96155781 | Cytomegalovirus: A Troll in the ICU? Overview of the Literature and Perspectives for the Future |
| Q46764122 | Delayed-onset primary cytomegalovirus disease and the risk of allograft failure and mortality after kidney transplantation |
| Q38053067 | Dendritic cell biology in human cytomegalovirus infection and the clinical consequences for host immunity and pathology |
| Q34402501 | Detection of human cytomegalovirus in different histological types of gliomas |
| Q45353001 | Drug-induced severe adverse reaction enhanced by human herpes virus-6 reactivation |
| Q38833951 | Early abnormal liver enzyme levels may increase the prevalence of human cytomegalovirus antigenaemia after hematopoietic stem cell transplantation |
| Q54918873 | Fulminant cytomegalovirus colitis complicating Staphylococcus aureus septicaemia and multiorgan failure in a previously immunocompetent patient. |
| Q35868670 | HCMV-encoded UL128 enhances TNF-α and IL-6 expression and promotes PBMC proliferation through the MAPK/ERK pathway in vitro |
| Q34579836 | Herpesvirus infections in organ transplant recipients |
| Q39997511 | Human Cytomegalovirus Inhibits Differentiation of Monocytes into Dendritic Cells with the Consequence of Depressed Immunological Functions |
| Q33618817 | Human cytomegalovirus Fcγ binding proteins gp34 and gp68 antagonize Fcγ receptors I, II and III |
| Q37104744 | Human cytomegalovirus infection and antiviral immunity in septic patients without canonical immunosuppression |
| Q39992541 | Human cytomegalovirus inhibits cytokine-induced macrophage differentiation |
| Q52586069 | Humoral immunity to memory antigens and pathogens is maintained in patients with chronic kidney disease. |
| Q37050965 | Immunobiology of human cytomegalovirus: from bench to bedside. |
| Q34294353 | Inhibition of cytomegalovirus immediate early gene expression: a therapeutic option? |
| Q36760142 | Intensity of the humoral response to cytomegalovirus is associated with the phenotypic and functional status of the immune system. |
| Q54237859 | Levels of anti-CMV antibodies are modulated by the frequency and intensity of virus reactivations in kidney transplant patients. |
| Q34294829 | Mechanisms of human cytomegalovirus (HCMV) (re)activation and its impact on organ transplant patients. |
| Q40163004 | Modification of the HCMV-specific IFN-γ release test (QuantiFERON-CMV) and a novel proposal for its application |
| Q52954259 | NF-kappaB--a potential therapeutic target for inhibition of human cytomegalovirus (re)activation? |
| Q34667638 | Neutrophils with myeloid derived suppressor function deplete arginine and constrain T cell function in septic shock patients |
| Q34380643 | Pattern of Viral Infections among Infants and Children Admitted to the Paediatric Intensive Care Unit at Sultan Qaboos University Hospital, Oman. |
| Q61864383 | Pneumonie virale sévère de l'immunocompétent |
| Q59138110 | Polymicrobial Sepsis Chronic Immunoparalysis Is Defined by Diminished Ag-Specific T Cell-Dependent B Cell Responses |
| Q58091387 | Polymicrobial sepsis influences NK-cell-mediated immunity by diminishing NK-cell-intrinsic receptor-mediated effector responses to viral ligands or infections |
| Q33740315 | Reactivation of multiple viruses in patients with sepsis |
| Q38111995 | Regulation of human cytomegalovirus transcription in latency: beyond the major immediate-early promoter |
| Q30301237 | Resistant pathogens, fungi, and viruses |
| Q44398534 | Risk factors for fatal infectious complications developing late after allogeneic stem cell transplantation |
| Q38377602 | Safety and Efficacy of Antiviral Therapy for Prevention of Cytomegalovirus Reactivation in Immunocompetent Critically Ill Patients: A Randomized Clinical Trial. |
| Q37055722 | Sepsis and cytomegalovirus: foes or conspirators? |
| Q49790787 | Sepsis-Induced T Cell Immunoparalysis: The Ins and Outs of Impaired T Cell Immunity. |
| Q59354720 | Spatio-temporal Virus Surveillance for Severe Acute Respiratory Infections in Resource-limited Settings: How Deep Need We Go? |
| Q33955684 | Synthetic oligonucleotides as therapeutics: the coming of age. |
| Q42090485 | TNF-alpha signaling is not required for in vivo transcriptional reactivation of latent murine cytomegalovirus |
| Q39462585 | The cytomegaloviral protein pUL138 acts as potentiator of tumor necrosis factor (TNF) receptor 1 surface density to enhance ULb'-encoded modulation of TNF-α signaling |
| Q33899616 | The cytomegalovirus-"safe" blood product: is leukoreduction equivalent to antibody screening? |
| Q43040318 | The pathogenesis of hepatitis C virus is influenced by cytomegalovirus |
| Q36862292 | Transplant-induced reactivation of murine cytomegalovirus immediate early gene expression is associated with recruitment of NF-κB and AP-1 to the major immediate early promoter. |
| Q33344063 | Unusual manifestations of primary cytomegalovirus infection in patients without HIV infection and without organ transplants |
| Q54422897 | Virological and immunological features of active cytomegalovirus infection in nonimmunosuppressed patients in a surgical and trauma intensive care unit. |
| Q40602726 | When Aging Reaches CD4+ T-Cells: Phenotypic and Functional Changes |
Search more.